Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 23 No 5 May/June 2018

Book of the Month

Cover of Drafting Commercial Agreements

Drafting Commercial Agreements

Price: £110.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Lowe legislation jp
Sealy millman 2018 jp
Desmith out now
Luba housing

Intellectual Property, Pharmaceuticals and Public Health : Access to Drugs in Developing Countries

Image not available lge
Edited by: Kenneth C. Shadlen, Alenka Guzman, N. Lalitha

ISBN13: 9781849800143
Published: November 2011
Publisher: Edward Elgar Publishing Limited
Country of Publication: UK
Format: Hardback
Price: £94.00
Paperback edition , ISBN13 9780857938794

Despatched in 4 to 6 days.

This book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.

Image not available lge
Intellectual Property Law, Medical Law
1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing
Health Gaps in the New International Environment Kenneth - C. Shadlen, Samira Guennif, Alenka Guzman
and Lalitha Narayanan
2. Pharmaceutical Production and Access to Essential Medicines in South Africa - Heinz Klug
3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy - Gaelle Krikorian
4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia - Tatiana Andia
5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS - Alenka Guzman
6. Corporate Power and State Resistance: Brazil's Use of TRIPS Flexibilities for its National AIDS Program - Matthew Flynn
7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies -
Kenneth C. Shadlen
8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience
Jean-Frederic Morin and Melanie Bourassa Forcier
9. Access to Indian Generic Drugs: Emerging Issues Lalitha Narayanan
10. Sufficient but Expensive Drugs: A Double Track System that Facilitated Supply Capability in China -
Mariko Watanabe and Luwen Shi
11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting
Public Health in a Developing Country Samira Guennif
12. The TRIPS Agreement and Health Innovation in Bangladesh - Padmashree Gehl Sampath